has role candesartan(2-) candesartan 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid PMID:23713902 440.45424 Patent:US5196444 C24H20N6O3 Wikipedia:Candesartan 0 HMDB:HMDB0014934 PMID:24464858 Blopress 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid LINCS:LSM-5903 chebi_ontology KEGG:C07468 DrugBank:DB00796 CAS:139481-59-7 440.15969 CCOc1nc2cccc(C(O)=O)c2n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid Beilstein:6377719 CV-11974 InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29) KEGG:D00522 Reaxys:6377719 A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension. Patent:EP459136 HTQMVQVXFRQIKW-UHFFFAOYSA-N CHEBI:3347 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid antihypertensive agent benzimidazolecarboxylic acid xenobiotic biphenylyltetrazole angiotensin receptor antagonist environmental contaminant